Literature DB >> 24174618

Heteromeric complexes of native collectin kidney 1 and collectin liver 1 are found in the circulation with MASPs and activate the complement system.

Maiken L Henriksen1, Jette Brandt, Jean-Piere Andrieu, Christian Nielsen, Pia H Jensen, Uffe Holmskov, Thomas J D Jorgensen, Yaseelan Palarasah, Nicole M Thielens, Soren Hansen.   

Abstract

The complement system is an important part of the innate immune system. The complement cascade may be initiated downstream of the lectin activation pathway upon binding of mannan-binding lectin, ficolins, or collectin kidney 1 (CL-K1, alias CL-11) to suitable microbial patterns consisting of carbohydrates or acetylated molecules. During purification and characterization of native CL-K1 from plasma, we observed that collectin liver 1 (CL-L1) was copurified. Based on deglycosylation and nonreduced/reduced two-dimensional SDS-PAGE, we detected CL-K1 and CL-L1 in disulfide bridge-stabilized complexes. Heteromeric complex formation in plasma was further shown by ELISA and transient coexpression. Judging from the migration pattern on two-dimensional SDS-PAGE, the majority of plasma CL-K1 was found in complex with CL-L1. The ratio of this complex was in favor of CL-K1, suggesting that a heteromeric subunit is composed of one CL-L1 and two CL-K1 polypeptide chains. We found that the complex bound to mannan-binding lectin-associated serine proteases (MASPs) with affinities in the nM range in vitro and was associated with both MASP-1/-3 and MASP-2 in plasma. Upon binding to mannan or DNA in the presence of MASP-2, the CL-L1-CL-K1 complex mediated deposition of C4b. In favor of large oligomers, the activity of the complex was partly determined by the oligomeric size, which may be influenced by an alternatively spliced variant of CL-K1. The activity of the native heteromeric complexes was superior to that of recombinant CL-K1. We conclude that CL-K1 exists in circulation in the form of heteromeric complexes with CL-L1 that interact with MASPs and can mediate complement activation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24174618     DOI: 10.4049/jimmunol.1302121

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

Review 1.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

2.  Collectin liver 1 and collectin kidney 1 and other complement-associated pattern recognition molecules in systemic lupus erythematosus.

Authors:  A Troldborg; S Thiel; L Jensen; S Hansen; M J Laska; B Deleuran; J C Jensenius; K Stengaard-Pedersen
Journal:  Clin Exp Immunol       Date:  2015-08-31       Impact factor: 4.330

3.  The pattern recognition molecule collectin-L1 in critically ill children.

Authors:  Catherine Ingels; Ilse Vanhorebeek; Inge Derese; Lisbeth Jensen; Pieter J Wouters; Steffen Thiel; Greet Van den Berghe
Journal:  Pediatr Res       Date:  2016-04-08       Impact factor: 3.756

Review 4.  Roles of pattern recognition receptors in diabetic nephropathy.

Authors:  Zhi-Feng Zhou; Lei Jiang; Qing Zhao; Yu Wang; Jing Zhou; Qin-Kai Chen; Jin-Lei Lv
Journal:  J Zhejiang Univ Sci B       Date:  2020 Mar.       Impact factor: 3.066

5.  Lectin complement pathway proteins in healthy individuals.

Authors:  A Troldborg; A Hansen; S W K Hansen; J C Jensenius; K Stengaard-Pedersen; S Thiel
Journal:  Clin Exp Immunol       Date:  2017-01-18       Impact factor: 4.330

6.  Collectin Kidney 1 Plays an Important Role in Innate Immunity against Streptococcus pneumoniae Infection.

Authors:  Insu Hwang; Kenichiro Mori; Katsuki Ohtani; Yasuyuki Matsuda; Nitai Roy; YounUck Kim; Yasuhiko Suzuki; Nobutaka Wakamiya
Journal:  J Innate Immun       Date:  2017-01-10       Impact factor: 7.349

7.  Circulating lectin pathway proteins do not predict short-term cardiac outcomes after myocardial infarction.

Authors:  C B Holt; J A Østergaard; S Thiel; T K Hansen; L Mellbin; P Sörensson; M Bjerre
Journal:  Clin Exp Immunol       Date:  2019-06-03       Impact factor: 4.330

8.  Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein.

Authors:  Anne-Laure Favier; Evelyne Gout; Olivier Reynard; Olivier Ferraris; Jean-Philippe Kleman; Viktor Volchkov; Christophe Peyrefitte; Nicole M Thielens
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

9.  Interaction of lectin pathway of complement-activating pattern recognition molecules with mycobacteria.

Authors:  M A Bartlomiejczyk; A S Swierzko; A Brzostek; J Dziadek; M Cedzynski
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

10.  Pattern Recognition Molecules of the Lectin Pathway-Screening of Patients with Suspected Immunodeficiency.

Authors:  Clara Mistegård Jørgensen; Lisbeth Jensen; Mette Christiansen; Mette Bjerre; Jens Magnus Bernth Jensen; Steffen Thiel
Journal:  J Clin Immunol       Date:  2019-08-03       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.